“Importantly, despite even potent modulation of the immune system, which results in profound reduction of inflammatory lesions, the effect on long-term disability and progression is not as robust as we would expect or hope for, and treatment of progressive disease has thus far been a failure”

Tsutsui S, Stys P. 2009.  “Degeneration versus autoimmunity in MS.”